Jones Andrew Simpson, Fenton John Eugene, Husband David John
Department of Otolaryngology/Head & Neck Surgery, University of Liverpool, Duncan Building, Daulby Street, Liverpool L69 3GA, United Kingdom.
Head Neck. 2003 Jan;25(1):24-31. doi: 10.1002/hed.10183.
Patients with tonsillar carcinoma and neck nodes seen at the clinic are not an uncommon occurrence in head and neck practice. Over the years, treatment has ranged from radical jaw neck dissection to radical neck dissection for the nodes and primary radiotherapy to the primary site. Much controversy exists as to which treatment modality yields the best survival. Certainly, surgery to the oropharynx leads to gross morbidity, with problems of swallowing, speech, and cosmesis, although it has been claimed that radiotherapy with neck dissection yields a lower cure rate.
We investigated a retrospective series of 96 patients all of whom had squamous cell carcinoma of the tonsil and associated lymph node metastases. Of these, 44 primary tumors were treated with surgery and 52 with irradiation. All 44 patients in the surgery group had a radical neck dissection, as did all but 12 in the radiotherapy group.
Of the tabulations, patients in good general condition were more likely to receive primary surgery. Overall cause-specific survival for all patients was 69%. Multiple logistic regression revealed no associations; thus, the radiotherapy and surgery groups were well matched. Five-year actuarial survival for those having irradiation was 74%. The five-year survival for the group receiving surgery was 63% (p =.4372). This lack of difference between survival for surgery and radiotherapy was confirmed using Cox's proportional hazards model.
We conclude that tonsillar carcinoma with lymph nodes can be safely treated by applying appropriate radiotherapy to the tonsillar region and treating the neck with radical surgery, if the disease is more than N1.
在头颈科临床中,扁桃体癌伴颈部淋巴结转移的患者并不少见。多年来,治疗方法从根治性颌颈清扫术到针对淋巴结的根治性颈清扫术,以及对原发部位进行单纯放疗。关于哪种治疗方式能带来最佳生存率存在诸多争议。当然,口咽手术会导致严重的并发症,如吞咽、言语和美观问题,尽管有人声称放疗联合颈清扫术的治愈率较低。
我们回顾性研究了96例患者,他们均患有扁桃体鳞状细胞癌及相关淋巴结转移。其中,44例原发肿瘤接受了手术治疗,52例接受了放疗。手术组的44例患者均进行了根治性颈清扫术,放疗组除12例患者外也都进行了根治性颈清扫术。
在统计数据中,一般状况良好的患者更有可能接受原发手术。所有患者的总体病因特异性生存率为69%。多因素logistic回归分析未发现相关性;因此,放疗组和手术组匹配良好。接受放疗患者的五年精算生存率为74%。接受手术治疗组的五年生存率为63%(p = 0.4372)。使用Cox比例风险模型证实了手术和放疗在生存率上没有差异。
我们得出结论,如果疾病分期超过N1期,对于伴有淋巴结转移的扁桃体癌,通过对扁桃体区域进行适当放疗并对颈部进行根治性手术,可以安全有效地进行治疗。